Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Breast Cancer

Free Subscription Articles published in BMC Cancer Retrieve available abstracts of 97 articles: HTML format Text format

Single Articles

February 2012
1. WU ZS , Wang CQ, Xiang R, Liu X, et al
   Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion.
   BMC Cancer. 2012;12:51.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
2. WU QW , She HQ, Liang J, Huang YF, et al
   Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer.
   BMC Cancer. 2012;12:47.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. AL SORKHY M , Ferraiuolo RM, Jalili E, Malysa A, et al
   The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer.
   BMC Cancer. 2012;12:45.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. MIEOG JS , de Kruijf EM, Bastiaannet E, Kuppen PJ, et al
   Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer.
   BMC Cancer. 2012;12:42.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. CAO MD , Giskeodegard GF, Bathen TF, Sitter B, et al
   Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.
   BMC Cancer. 2012;12:39.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. CHENG TF , Wang JD, Uen WC
   Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer.
   BMC Cancer. 2012;12:33.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. YU X , Zhang X, Dhakal IB, Beggs M, et al
   Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.
   BMC Cancer. 2012;12:29.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. GOMES LR , Terra LF, Wailemann RA, Labriola L, et al
   TGF-beta1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.
   BMC Cancer. 2012;12:26.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. DE KRUIJF EM , Sajet A, van Nes JG, Putter H, et al
   NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study.
   BMC Cancer. 2012;12:24.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. MARSDEN CG , Wright MJ, Carrier L, Moroz K, et al
    "A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies"
    BMC Cancer. 2012;12:10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
11. VOLLAN HK , Caldas C
    The breast cancer genome - a key for better oncology.
    BMC Cancer. 2011;11:501.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. ELLBERG C , Olsson H
    Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer.
    BMC Cancer. 2011;11:497.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. SU FH , Chang SN, Chen PC, Sung FC, et al
    Association between Chronic Viral Hepatitis Infection and Breast Cancer Risk: a Nationwide Population-based Case-control Study.
    BMC Cancer. 2011;11:495.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. FASCHING PA , Heusinger K, Haberle L, Niklos M, et al
    Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment.
    BMC Cancer. 2011;11:486.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. HAHN T , Bradley-Dunlop DJ, Hurley LH, Von-Hoff D, et al
    The vitamin E analog alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer.
    BMC Cancer. 2011;11:471.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
16. KEAM B , Im SA, Koh Y, Han SW, et al
    Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy.
    BMC Cancer. 2011;11:452.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. KANEKO K , Ishigami S, Kijima Y, Funasako Y, et al
    Clinical implication of HLA class I expression in breast cancer.
    BMC Cancer. 2011;11:454.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. GLYNN RW , Kelly JC, Coffey N, Sweeney KJ, et al
    The effect of breast cancer awareness month on internet search activity - a comparison with awareness campaigns for lung and prostate cancer.
    BMC Cancer. 2011;11:442.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. STRATI A , Markou A, Parisi C, Politaki E, et al
    Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR.
    BMC Cancer. 2011;11:422.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. DRAGOWSKA WH , Weppler SA, Qadir MA, Wong LY, et al
    The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity.
    BMC Cancer. 2011;11:420.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
21. OLSSON E , Honeth G, Bendahl PO, Saal LH, et al
    CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
    BMC Cancer. 2011;11:418.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. YOUL PH , Baade PD, Aitken JF, Chambers SK, et al
    A multilevel investigation of inequalities in clinical and psychosocial outcomes for women after breast cancer.
    BMC Cancer. 2011;11:415.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. TOBIN NP , Sims AH, Lundgren KL, Lehn S, et al
    Cyclin D1, Id1 and EMT in Breast cancer.
    BMC Cancer. 2011;11:417.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. ZHAO X , Xu X, Zhang Q, Jia Z, et al
    Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid.
    BMC Cancer. 2011;11:403.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. JUNOD B , Zahl PH, Kaplan RM, Olsen J, et al
    An Investigation of the Apparent Breast Cancer Epidemic in France: Screening and incidence trends in birth cohorts.
    BMC Cancer. 2011;11:401.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. LE SCODAN R , Jouanneau L, Massard C, Gutierrez M, et al
    Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death.
    BMC Cancer. 2011;11:395.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. XU F , Li D, Zhang Q, Fu Z, et al
    ICOS gene polymorphisms are associated with sporadic breast cancer: a case-control study.
    BMC Cancer. 2011;11:392.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
28. BODY JJ
    Increased Fracture Rate in Women With Breast Cancer: a Review of the Hidden Risk.
    BMC Cancer. 2011;11:384.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. KHEIRELSEID EA , Boggs JM, Curran C, Glynn RW, et al
    Younger age as a prognostic indicator in breast cancer: A cohort study.
    BMC Cancer. 2011;11:383.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. OPSTAL-VAN WINDEN AW , Krop EJ, Karedal MH, Gast MC, et al
    Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study.
    BMC Cancer. 2011;11:381.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. LEPORE SJ , Buzaglo JS, Lieberman MA, Golant M, et al
    Standard Versus Prosocial Online Support Groups for Distressed Breast Cancer Survivors: A Randomized Controlled Trial.
    BMC Cancer. 2011;11:379.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. FIEGL M , Mlineritsch B, Hubalek M, Bartsch R, et al
    Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial.
    BMC Cancer. 2011;11:373.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. PAN SY , Zhou J, Gibbons L, Morrison H, et al
    Antioxidants and breast cancer risk - a population-based case-control study in Canada.
    BMC Cancer. 2011;11:372.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. LI J , Zhang BN, Fan JH, Pang Y, et al
    A Nation-Wide Multicenter 10-year (1999-2008) Retrospective Clinical Epidemiological Study of Female Breast Cancer in China.
    BMC Cancer. 2011;11:364.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. DE BAZELAIRE C , Calmon R, Thomassin I, Brunon C, et al
    Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study.
    BMC Cancer. 2011;11:361.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. STAVIK B , Skretting G, Aasheim HC, Tinholt M, et al
    Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility.
    BMC Cancer. 2011;11:357.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. BOSTROM P , Soderstrom M, Vahlberg T, Soderstrom KO, et al
    MMP-1 expression has an independent prognostic value in breast cancer.
    BMC Cancer. 2011;11:348.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. ROMERO Q , Bendahl PO, Klintman M, Loman N, et al
    Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies.
    BMC Cancer. 2011;11:341.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. KANG JH , Song KH, Jeong KC, Kim S, et al
    Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells.
    BMC Cancer. 2011;11:334.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. FOERSTER R , Foerster FG, Wulff V, Schubotz B, et al
    Matched-pair analysis of patients with female and male breast cancer: a comparative analysis.
    BMC Cancer. 2011;11:335.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
41. PITUSKIN E , Haykowsky M, Mackey JR, Thompson RB, et al
    Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101 - Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent tra
    BMC Cancer. 2011;11:318.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. SADANANDAM A , Futakuchi M, Lyssiotis CA, Gibb WJ, et al
    A Cross-Species Analysis of a Mouse Model of Breast Cancer-Specific Osteolysis and Human Bone Metastases using Gene Expression Profiling.
    BMC Cancer. 2011;11:304.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. ALBERGARIA A , Ricardo S, Milanezi F, Carneiro V, et al
    Nottingham Prognostic Index in Triple-Negative Breast Cancer: A reliable prognostic tool?
    BMC Cancer. 2011;11:299.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. TAHERIAN A , Li X, Liu Y, Haas TA, et al
    Differences in integrin expression and signaling within human breast cancer cells.
    BMC Cancer. 2011;11:293.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. SU Y , Zheng Y, Zheng W, Gu K, et al
    Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study.
    BMC Cancer. 2011;11:292.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. FALVO E , Strigari L, Citro G, Giordano C, et al
    Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of developing erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery.
    BMC Cancer. 2011;11:291.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. FANG XJ , Jiang H, Zhao XP, Jiang WM, et al
    The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.
    BMC Cancer. 2011;11:290.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. SEDLACEK SM , Playdon MC, Wolfe P, McGinley JN, et al
    Effect of a Low Fat versus a Low Carbohydrate Weight Loss Dietary Intervention on Biomarkers of Long Term Survival in Breast Cancer Patients ('CHOICE'): Study Protocol.
    BMC Cancer. 2011;11:287.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
49. LU W , Jansen L, Schaapveld M, Baas PC, et al
    Underuse of long-term routine hospital follow-up care in patients with a history of breast cancer?
    BMC Cancer. 2011;11:279.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. RICKS-SANTI LJ , Sucheston LE, Yang Y, Freudenheim JL, et al
    Association of Rad51 polymorphism with DNA repair in BRCA1 Mutation Carriers and Sporadic Breast Cancer Risk.
    BMC Cancer. 2011;11:278.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. KAPLAN HG , Malmgren JA, Atwood MK
    Increased Incidence of Myelodysplastic Syndrome and Acute Myeloid Leukemia Following Breast Cancer Treatment with Radiation Alone or Combined with Chemotherapy: a registry cohort analysis 1990-2005.
    BMC Cancer. 2011;11:260.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. GRUNDY M , Seedhouse C, Russell NH, Pallis M, et al
    P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the Aurora-B kinase inhibitor barasertib-hQPA.
    BMC Cancer. 2011;11:254.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. SADI AM , Wang DY, Youngson BJ, Miller N, et al
    Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.
    BMC Cancer. 2011;11:253.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. SOLA M , Margeli M, Castella E, Julian JF, et al
    Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients. A prospective observational study.
    BMC Cancer. 2011;11:252.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. VERA-LLONCH M , Weycker D, Glass A, Gao S, et al
    Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality.
    BMC Cancer. 2011;11:250.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. ASKOXYLAKIS V , Jensen AD, Hafner MF, Fetzner L, et al
    Simultaneous integrated boost for adjuvant treatment of breast cancer- Intensity modulated vs. conventional radiotherapy: The IMRT-MC2 trial.
    BMC Cancer. 2011;11:249.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. CHEN Y , Xu J, Borowicz S, Collins C, et al
    c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells.
    BMC Cancer. 2011;11:246.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. ROBEY IF , Martin NK
    Bicarbonate and dichloroacetate: Evaluating pH altering therapies in a mouse model for metastatic breast cancer.
    BMC Cancer. 2011;11:235.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. ABRHALE T , Brodie A, Sabnis G, Macedo L, et al
    GP88 (PC-Cell Derived Growth Factor, Progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells.
    BMC Cancer. 2011;11:231.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. PRESSON AP , Yoon NK, Bagryanova L, Mah V, et al
    Protein expression based multimarker analysis of breast cancer samples.
    BMC Cancer. 2011;11:230.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. MA H , Carpenter CL, Sullivan-Halley J, Bernstein L, et al
    The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors - results of a prospective study.
    BMC Cancer. 2011;11:222.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. DE CREMOUX P , Valet F, Gentien D, Lehmann-Che J, et al
    Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients.
    BMC Cancer. 2011;11:215.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
63. CASSIER PA , Treilleux I, Bachelot T, Ray-Coquard I, et al
    Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer.
    BMC Cancer. 2011;11:213.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. MULLER AC , Eckert F, Heinrich V, Bamberg M, et al
    Re-surgery and chest wall re-irradiation for recurrent breast cancer - a second curative approach.
    BMC Cancer. 2011;11:197.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. CARLES M , Vilaprinyo E, Cots F, Gregori A, et al
    Cost-effectiveness of early detection of breast cancer in Catalonia (Spain).
    BMC Cancer. 2011;11:192.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. GOH J , Enns L, Fatemie S, Hopkins H, et al
    Mitochondrial targeted catalase suppresses invasive breast cancer in mice.
    BMC Cancer. 2011;11:191.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. LOPES GD
    Societal Costs and Benefits of Treatment with Trastuzumab in Patients with Early HER2neu-Overexpressing Breast Cancer in Singapore.
    BMC Cancer. 2011;11:178.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. WALKER LG , Eremin JM, Aloysius MM, Vassanasiri W, et al
    Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women
    BMC Cancer. 2011;11:179.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. VOSS MJ , Moller MF, Powe DG, Niggemann B, et al
    Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism.
    BMC Cancer. 2011;11:158.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
70. MILLET I , Bouic-Pages E, Hoa D, Azria D, et al
    Growth of breast cancer recurrences assessed by consecutive MRI.
    BMC Cancer. 2011;11:155.
    PubMed     Text format     Related articles   
    
    
    
    
71. ASSUMPCAO JG , Seidinger AL, Mastellato MJ, Ribeiro RC, et al
    Correction: Association of the germline TP53 R337H mutation with breast cancer in southern Brazil.
    BMC Cancer. 2011;11:152.
    PubMed     Text format     Related articles   
    
    
    
    
72. ALTENBURG JD , Bieberich AA, Terry C, Harvey KA, et al
    A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.
    BMC Cancer. 2011;11:149.
    PubMed     Text format     Related articles   
    
    
    
    
73. RIDAO-LOPEZ M , Garcia-Armesto S, Abadia-Taira B, Peiro-Moreno S, et al
    Income level and regional policies, underlying factors associated with unwarranted variations in conservative breast cancer surgery in Spain.
    BMC Cancer. 2011;11:145.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. KAO KJ , Chang KM, Hsu HC, Huang AT, et al
    Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.
    BMC Cancer. 2011;11:143.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. NORSA'ADAH B , Rampal KG, Rahmah MA, Naing NN, et al
    Diagnosis delay of breast cancer and its associated factors in Malaysian women.
    BMC Cancer. 2011;11:141.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. KANTELHARDT EJ , Vetter M, Schmidt M, Veyret C, et al
    Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 x FEC versus 3 x FEC / 3 x Docetaxel.
    BMC Cancer. 2011;11:140.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. LOIBL S , Skacel T, Nekljudova V, Luck HJ, et al
    Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis.
    BMC Cancer. 2011;11:131.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. SORIA G , Ofri-Shahak M, Haas I, Yaal-Hahoshen N, et al
    Inflammatory mediators in breast cancer: Coordinated expression of TNFalpha & IL-1beta with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition.
    BMC Cancer. 2011;11:130.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. SCHOTT S , Schneeweiss A, Reinhardt J, Bruckner T, et al
    Acceptance of oral chemotherapy in breast cancer patients - a survey study.
    BMC Cancer. 2011;11:129.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
80. SHIGEMATSU H , Kawaguchi H, Nakamura Y, Tanaka K, et al
    Significant survival improvement of patients with recurrent breast cancer in the periods 2001-2008 vs. 1992-2000.
    BMC Cancer. 2011;11:118.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. ALKNER S , Bendahl PO, Ferno M, Manjer J, et al
    Prediction of outcome after diagnosis of metachronous contralateral breast cancer.
    BMC Cancer. 2011;11:114.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. ZENG G , Cai S, Wu GJ
    Up-regulation of METCAM/MUC18 Promotes Motility, Invasion, and Tumorigenesis of Human Breast Cancer Cells.
    BMC Cancer. 2011;11:113.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. LOPEZ MARTIN M , Hernandez MA, Avendano C, Rodriguez F, et al
    Manual lymphatic drainage therapy in patients with breast cancer related lymphoedema.
    BMC Cancer. 2011;11:94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
84. NUZZO F , Morabito A, Gravina A, Di Rella F, et al
    Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial.
    BMC Cancer. 2011;11:75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. LINHER-MELVILLE K , Zantinge S, Sanli T, Gerstein H, et al
    Establishing a relationship between prolactin and altered fatty acid beta-Oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
    BMC Cancer. 2011;11:56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
86. GOSTNER JM , Fong D, Wrulich OA, Lehne F, et al
    Effects of EpCAM overexpression on human breast cancer cell lines.
    BMC Cancer. 2011;11:45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. MANN E , Smith M, Hellier J, Hunter MS, et al
    A randomised controlled trial of a cognitive behavioural intervention for women who have menopausal symptoms following breast cancer treatment (MENOS 1): Trial protocol.
    BMC Cancer. 2011;11:44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. ZHANG G , Brewster A, Guan B, Fan Z, et al
    Tumor-suppressor activity of RRIG1 in breast cancer.
    BMC Cancer. 2011;11:32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. JENSEN AO , Jacobsen JB, Norgaard M, Yong M, et al
    Incidence of bone metastases and skeletal-related events in breast cancer patients: A population-based cohort study in Denmark.
    BMC Cancer. 2011;11:29.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. HEDAU S , Kumar U, Hussain S, Shukla S, et al
    Breast cancer and human papillomavirus infection: No evidence of HPV etiology of breast cancer in Indian women.
    BMC Cancer. 2011;11:27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. BEAUSOLEIL MS , Schulze EB, Goodale D, Postenka CO, et al
    Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.
    BMC Cancer. 2011;11:25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. ZOU CF , Jia L, Jin H, Yao M, et al
    Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer Cells and enhances the inhibitory effect of paclitaxel.
    BMC Cancer. 2011;11:22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. LORENTZEN A , Lewinsky RH, Bornholdt J, Vogel LK, et al
    Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer.
    BMC Cancer. 2011;11:14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. WEVERS MR , Ausems MG, Verhoef S, Bleiker EM, et al
    Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: Design of a multicenter randomized clinical trial.
    BMC Cancer. 2011;11:6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. ROTH C , Pantel K, Muller V, Rack B, et al
    Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression.
    BMC Cancer. 2011;11:4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. MORGAN K , Meyer C, Miller N, Sims AH, et al
    GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines.
    BMC Cancer. 2011;11:476.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. KANG HS , Lee SC, Park YS, Jeon YE, et al
    Protein and lipid MALDI profiles classify breast cancers according to the intrinsic subtype.
    BMC Cancer. 2011;11:465.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: